We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LION:NYSELionsgate Studios Corp Analysis

Data as of 2026-06-13 - not real-time

$14.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Lionsgate Studios Corp. (LION) is trading above its short‑term moving averages, indicating bullish price action. The price sits above the 20‑day SMA and the 50‑day SMA while remaining below the 200‑day SMA, suggesting momentum in the near term. RSI is in the mid‑60s, pointing to continued upward pressure without being extreme. MACD shows a bearish histogram, hinting at a possible short‑term pullback. Volume trends are decreasing, which could limit upside in the immediate horizon. Recent earnings beat, with EPS surpassing consensus estimates, and an analyst upgrade to Buy reinforce improving earnings visibility. The forward PE near 36× earnings and a negative price‑to‑book ratio signal that valuation remains stretched. Strong library revenue and strategic AI initiatives provide a growth narrative that supports a higher multiple. Market sentiment is extremely bullish, as reflected by an “Extreme Greed” reading on the fear‑greed index. Overall, the stock presents a mixed bag of bullish technical momentum and growth catalysts tempered by elevated valuation and heightened volatility.
Investors should weigh the strong earnings momentum against the lofty valuation and volatility before deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with decreasing volume
  • Bearish MACD histogram suggests short‑term pullback
  • RSI still indicating upward pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Earnings beat and analyst upgrade to Buy
  • Strong library revenue and AI initiatives
  • Bullish trend direction and RSI support

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated forward PE and negative price‑to‑book
  • High 30‑day volatility
  • Growth narrative balanced by valuation concerns

Key Metrics & Analysis

Financial Health

P/E Ratio35.8
P/B Ratio-3.5

Technical Analysis

TrendBullish
RSI64.9
Support$12.23
Resistance$15.01
MA 20$13.62
MA 50$12.43
MA 200$9.06
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Target Price$15.00
Upside/Downside4.75%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.94
Volatility52.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.